Your browser doesn't support javascript.
loading
Predicting Drug-Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling.
Rajoli, Rajith K R; Curley, Paul; Chiong, Justin; Back, David; Flexner, Charles; Owen, Andrew; Siccardi, Marco.
Afiliación
  • Rajoli RKR; Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom.
  • Curley P; Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom.
  • Chiong J; Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom.
  • Back D; Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom.
  • Flexner C; Johns Hopkins University School of Medicine and Bloomberg School of Public Health, Baltimore, Maryland.
  • Owen A; Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom.
  • Siccardi M; Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom.
J Infect Dis ; 219(11): 1735-1742, 2019 05 05.
Article en En | MEDLINE | ID: mdl-30566691

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridonas / Rifampin / Infecciones por VIH / Antirretrovirales / Rilpivirina Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Infect Dis Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridonas / Rifampin / Infecciones por VIH / Antirretrovirales / Rilpivirina Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Infect Dis Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido